Our first Horizon2020 project is coming to an end. Openmind enabled a 4 year cooperation between 9 partners from 6 countries to deliver on demand medical devices. Do you want to participate in the final workshop of the consortium, please send us a mail. The workshop starts at 09:30 and is held at the Fraunhofer IPT in Aachen. The workshop will be very interesting for those 1) interested in the new medical device regulatiom, 2) meeting new SME partners active in the medical device manufacturing, and 3) seeing first prototype manufacturing system for on demand production.
PICS will be focusing on the latest interventional catheter strategies for congenital and structural heart disease in children and adults. Therefore we are eager to exhibit for first time at this annual meeting in September 2018, and look forward to share our product and process know-how on moving your cathlab procedures to the MRI. .
Step by our Booth 124 to meet the team and learn more about our products!
See you in Vegas!!
AEPC 2018 is taking place between May 9th and 11th in Athens. We are proud to be a bronze sponsor of this meeting and are happy to welcome you during our lunch workshop on May 10 th (13:30, Kokkali Hall) on management of hemodynamics in congenital heart diseases using MRI guidance. Speakers will be dr Tzifa (MITERA, Athens), dr Tanase (DHZ Munich) and dr Muturangu (GOSH, London). All speakers have long -standing experience with cathlab procedures in this group, as well as with MRI guided caths, including our new EmeryGlide guidewire. There will also be opportunity to use our products in a real-scale phantom to get a grip on this matter. Apart from this our experts can share with you individual experience about making the transition from Cathlab to MRI for these procedures.
See you in Athens!
CMR 2018 was again a major step forward for interventional MRI. CMR 2018 focused on the theme of “Improving Clinical Value by Technical Advances,” emphasizing the goal of both Societies to improve clinical outcomes in cardiovascular disease through innovation. This paved the way for a complete afternoon session with a line-up of speakers showing recent advances in their centers (e.g Dallas Childrens, RFH London, Helios Leipzig) and others (e.g. San Diego, NIH, Munich) pointing at the next indications to do in MRI. After SCMR 2017 in Washington also a live case of interventional MRI was broadcasted into the plenary meeting, this time from Kings College, London by Reza Rezavi. Notably, many American clinicians were happy that an FDA registered product is now available via Nano4Imaging. It was also clear from the meeting that a lot of our customers have to go through the same cumbersome pathway with hospital authorities, platform suppliers and many others. Nano4Imaging will launch a platform soon to share best practices and connect customers.
It was a fascinating event this week. The Techtour landing in the Brightlands area with the Benelux Venture Forum and having meetings all over its different locations in Maastricht, Heerlen and Geleen. It gave Nano4Imaging the opportunity to pitch in the Life Sciences session for a group of investors. Pitching on a boat lying on the Meuse river in Maastricht and having great networking opportunities with local and international networks. Our message : strategic partner sought for introduction of our products in the USA.
With a new energy boost we are now starting to prepare our participation at CMR in Barcelona (Jan 2018). FDA has approved the special 510K for our second generation MR compatible guide wire, and we are awaiting CE approval also soon. Next year you will see us at Barcelona CMR 2018, the world symposium on Pulmonary Hypertension (Nice) and AEPC 2018 in Athens. Let’s roll.
On June 28th and 29th 2017, Nano4Imaging participated in the first edition of the MedFit meeting in Grenoble’s (France) Alpexpo. The set-up was unique in a mix of very lively panel discussions on different angles of medical device development (regulation, collaboration, investment and innovation) and was an inspiring environment and scale to meet with leading experts from corporates, VCs, serial entrepreneurs and start-ups. An inspiring mix of people and topics that deserves further extension on European level, where revitalisation of the classical MedTech meetings is welcome..
EuroCMR 2017 in Prague was attended by 1022 participants, which was another 35 % rise over Florence last year.The meeting was between 25- 27th of May and hosted by the Clarion Congress Hotel in Prague (CZ). Topics included Big data and CMR ( S Petersen) and impressive contributions on the Improving of heath care through Imaging (Joerg Schwitter) as well as Imaging Biomarkers controversies (G. Cole). A good opportunity for Nano4Imaging to meet its clinical relations and plan further clinical work.
Dr Pushparajah (KCL) showed an excellent overview of the MRI guided catheter procedures including data of our recent PMCF in Munich.
Dr Vivek Muthurangu, as always made his take home message on MRI in Pulmonary hypertension simple: go out and do it!!
Nano4Imaging is the proud winner of the first Ralf Raue Innovation award, as a reward for its continuous and extensive cross-border cooperation between Germany and Netherlands. On May 10th our CSO Paul Borm proudly accepted the price handed by Ria Hein (Brabant Investment) in the Auditorium at Technical University Eindhoven. The motivation of the jury reads” there are no borders for Nano4Imaging since it just uses the expertise wherever it is in Europe“. It further states that N4I has very strong links with clinical centers in the Netherlands (Maastricht, Utrecht, Nijmegen) and joint development projects with these clinical centers.
After the live case in Washington at SCMR2017, now also ISMRM which gathers more then 5000 specialists in MRI, had a live broadcast of real time cardiac MRI in a plenary session on April 25th. Among several speakers it was prof. Razavi who explained the value of interventional MRI in cardiac diagnostics and interventions. His research group at King’s College London has been the first to apply real-time MRI to congenital heart disease more than 15 years ago.